Transgene Quote - TNG

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.695

Bid

0.695

Ask

0.70

Volume

10,900

0.695 Day's Range 0.705

0.695 52 Week Range 1.52

Market Cap

70.093M

Previous Close

0.70

Open

0.70

Last Trade

133

0.695

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

37,796

Shares Outstanding

100,852,742

Dividend Yield

PE Ratio

-3.12

Earnings Per Share (EPS)

-0.22

Revenue

7.9M

Net Profit

-22.33M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.transgene.fr

Headquarters

Illkirch-graffenstaden, Bas-rhin, Fra

Founded

Transgene SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker TNG. The last closing price for Transgene was 0.70 €. Over the last year, Transgene shares have traded in a share price range of 0.695 € to 1.52 €.

Transgene currently has 100,852,742 shares outstanding. The market capitalization of Transgene is 70.60 € million. Transgene has a price to earnings ratio (PE ratio) of -3.12.

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024 Les données de...

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant standard of care remain disease-free TG4050 induced...

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Compelling 24.1-month median follow-up data...

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024 TG4050 : Données prometteuses de Phase I présentées au SITC 2024 confirmant une...

Transgene Reports Business, Pipeline and Financial Update for Q3 2024

Transgene Reports Business, Pipeline and Financial Update for Q3 2024 TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck...

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a...

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés Strasbourg (France), Berlin (Germany), le 5 novembre 2024, 7 h 30 Transgene...

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers Top line data show that the randomized...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.021	-2.93296089385	0.716	0.729	0.695	21293	0.70695122	DE
4	-0.065	-8.55263157895	0.76	0.8	0.695	27462	0.73297932	DE
12	-0.415	-37.3873873874	1.11	1.204	0.695	37796	0.90679469	DE
26	-0.405	-36.8181818182	1.1	1.21	0.695	28540	0.97850706	DE
52	-0.615	-46.9465648855	1.31	1.52	0.695	30417	1.1291804	DE
156	-1.935	-73.5741444867	2.63	2.775	0.695	33944	1.79280498	DE
260	-0.855	-55.1612903226	1.55	3.15	0.695	73082	1.98226656	DE

TNG - Frequently Asked Questions (FAQ)

What is the current Transgene share price?

The current share price of Transgene is 0.695 €

How many Transgene shares are in issue?

Transgene has 100,852,742 shares in issue

What is the market cap of Transgene?

The market capitalisation of Transgene is EUR 70.6M

What is the 1 year trading range for Transgene share price?

Transgene has traded in the range of 0.695 € to 1.52 € during the past year

What is the PE ratio of Transgene?

The price to earnings ratio of Transgene is -3.12

What is the cash to sales ratio of Transgene?

The cash to sales ratio of Transgene is 8.81

What is the reporting currency for Transgene?

Transgene reports financial results in EUR

What is the latest annual turnover for Transgene?

The latest annual turnover of Transgene is EUR 7.9M

What is the latest annual profit for Transgene?

The latest annual profit of Transgene is EUR -22.33M

What is the registered address of Transgene?

The registered address for Transgene is 400 BOULEVARD GONTHIER D’ANDERNACH-PARC D'INNOVATION, ILLKIRCH-GRAFFENSTADEN, BAS-RHIN, 67405

What is the Transgene website address?

The website address for Transgene is www.transgene.fr

Which industry sector does Transgene operate in?

Transgene operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EIFDSTour Eiffel DS	0.0432 € (800.00%)	89.74k
SEQUASequana medical NV	2.76 € (33.33%)	1.64M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M
ALPAUPaulic Meunerie SA	1.43 € (16.26%)	17.14k
GNROGeNeuro SA	0.081 € (15.38%)	330.33k
MLSMLSmalto	0.0125 € (-32.43%)	50
ALVIAVialife Sa	13.30 € (-27.72%)	7
MLMADMade	9.25 € (-15.91%)	255
ALALOAcheterLouerFR	0.23 € (-14.81%)	3.92k
ALLPLLepermislibre SA	0.397 € (-11.78%)	3.01k
ATOAtos SE	0.0023 € (-4.17%)	396.59M
BCPBanco Comercial Portugues SA	0.451 € (0.16%)	17.85M
LATLatecoere	0.0094 € (3.30%)	9.13M
ALVERVergnet	0.0021 € (-4.55%)	8.37M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M